BRCA2 and breast carcinoma: In a recent study of Spanish breast and/or ovarian cancer families, the haplotype lacking the Ins16 allele (referred to as "Ins16minus") and containing the 72Pro allele was associated with a younger age of diagnosis of breast cancer in BRCA2 mutation carriers than other comparative groups based on BRCA mutation status [45].